INVA — Innoviva Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapSuper Stock

Annual cashflow statement for Innoviva, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	294	369	220	180	23.4
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	-40.6	-78.4	-69.9	-54	145
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-14.3	-16.9	6.87	-24.8	-6.93
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	313	364	202	141	189
Capital Expenditures	-0.013	0	-0.067	-0.411	-4.27
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-315	43.7	-56.6	-66.3	-59.5
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities	-315	43.7	-56.6	-66.8	-63.8
Financing Cash Flow Items	-30.1	-59.5	-114	0	0
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-29.8	-452	-55.6	-172	-13.5
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-31.6	-45	89.5	-97.5	111